Company intelligence / Profile preview

Kona Medical

Bellevue, Washington, United Stateskonamedicalconsulting.com ↗

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Kona Medical has developed a non-invasive focused ultrasound device for renal denervation to treat resistant hypertension. Early clinical trials showed promising results with approximately three quarters of patients responding at six months and an excellent safety profile. The company initiated the WAVE IV trial—a randomized, sham-controlled study—to further evaluate efficacy and safety. The technology remains investigational and not yet approved for sale.

Therapeutic areas: CardiovascularNephrology
Modalities: DeviceNon-pharmacological therapy (Focused ultrasound)
Industry: Therapeutic Medical Devices

Partnerships

Morningside Group (lead investor with strategic focus on China market)

Beyond the preview

Go deeper on Kona Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kona Medical.

Explore the full profile